Cited by 510RNA Research and SplicingGenetic Neurodegenerative DiseasesMuscle Physiology and Disorders

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy

Lin, Xiaoyan, Miller, Jill W., Mankodi, Ami, Kanadia, Rahul N., Yuan, Yuan, Moxley, Richard T., Swanson, Maurice S., Thornton, Charles A.·2006·Human Molecular Genetics

DOI 10.1093/hmg/ddl132

Open this paper in CoChat — free account

Abstract

In myotonic dystrophy (DM), expression of RNA containing expanded CUG or CCUG repeats leads to misregulated alternative splicing of pre-mRNA. The repeat-bearing transcripts accumulate in nuclear foci, together with proteins in the muscleblind family, MBNL1 and MBNL2. In transgenic mice that express expanded CUG repeats, we show that the splicing defect selectively targets a group of exons that share a common temporal pattern of developmental regulation. These exons undergo a synchronized splicing switch between post-natal day 2 and 20 in wild-type mice. During this post-natal interval, MBNL1 protein translocates from a predominantly cytoplasmic to nuclear distribution. In the absence of MBNL1, these physiological splicing transitions do not occur. The splicing defect induced by expanded CUG repeats in mature muscle fibers is closely reproduced by deficiency of MBNL1 but not by deficiency of MBNL2. A parallel situation exists in human DM type 1 and type 2. MBNL1 is depleted from the muscle nucleoplasm because of sequestration in nuclear foci, and the associated splicing defects are remarkably similar to those observed in MBNL1 knockout mice. These results indicate that MBNL1 participates in the post-natal remodeling of skeletal muscle by controlling a key set of developmentally regulated splicing switches. Sequestration of MBNL1, and failure to maintain these splicing transitions, has a pivotal role in the pathogenesis of muscle disease in DM.

Integrity signals

Registry

Crossref · 10.1093/hmg/ddl132

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A., Church, D. M., Aburatani, H., Hunter, K. W., Stanton, V. P., Thirion, J., Hudson, T. J., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,754
Ultraconserved Elements in the Human Genome
Bejerano, G., Pheasant, M., Makunin, I., Stephen, S., Kent, W. J., Mattick, J. S., & Haussler, D. (2004) · Science · doi:10.1126/science.1098119 · Cited by 1,732
Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9
Liquori, C. L., Ricker, K., Moseley, M. L., Jacobsen, J. F., Kreß, W., Naylor, S. L., Day, J., & Ranum, L. P. W. (2001) · Science · doi:10.1126/science.1062125 · Cited by 1,254
Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy
Miller, J. W., Urbinati, C. R., Teng‐umnuay, P., Stenberg, M. G., Byrne, B. J., Thornton, C. A., & Swanson, M. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4439 · Cited by 937
Self-citation
Disruption of Splicing Regulated by a CUG-Binding Protein in Myotonic Dystrophy
Philips, A. V., Timchenko, L., & Cooper, T. A. (1998) · Science · doi:10.1126/science.280.5364.737 · Cited by 818
The Polo kinase Plk4 functions in centriole duplication
Habedanck, R., Stierhof, Y., Wilkinson, C. J., & Nigg, E. A. (2005) · Nature Cell Biology · doi:10.1038/ncb1320 · Cited by 809
Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy
Savkur, R. S., Philips, A. V., & Cooper, T. A. (2001) · Nature Genetics · doi:10.1038/ng704 · Cited by 795
A Muscleblind Knockout Model for Myotonic Dystrophy
Kanadia, R. N., Johnstone, K. A., Mankodi, A., Lungu, C., Thornton, C. A., Esson, D., Timmers, A. M., Hauswirth, W. W., & Swanson, M. S. (2003) · Science · doi:10.1126/science.1088583 · Cited by 743
Self-citation
Myotonic Dystrophy in Transgenic Mice Expressing an Expanded CUG Repeat
Mankodi, A. K., Logigian, E. L., Callahan, L. M., McClain, C., White, R. J., Henderson, D., Krym, M., & Thornton, C. A. (2000) · Science · doi:10.1126/science.289.5485.1769 · Cited by 738
Self-citation
Expanded CUG Repeats Trigger Aberrant Splicing of ClC-1 Chloride Channel Pre-mRNA and Hyperexcitability of Skeletal Muscle in Myotonic Dystrophy
Mankodi, A. K., Takahashi, M. P., Jiang, H. N., Beck, C. L., Bowers, W. J., Moxley, R. T., Cannon, S. C., & Thornton, C. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00563-4 · Cited by 672
Self-citation

Flagged first, then by citations

Show all 35 references

Sorted by citations

Items 101–200 of 509

Myotonic Dystrophies 1 and 2: Complex Diseases with Complex Mechanisms
Schoser, B. G. H., & Timchenko, L. (2010) · Current Genomics · doi:10.2174/138920210790886844 · Cited by 88
Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1
Thornell, L. E., Lindstöm, M., Renault, V. M., Klein, A. F., Mouly, V., Ansved, T., Butler-Browne, G. S., & Furling, D. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01014.x · Cited by 88
Myotonic dystrophy, when simple repeats reveal complex pathogenic entities: new findings and future challenges
Sicot, G., Gourdon, G., & Gomes-Pereira, M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr343 · Cited by 93
Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study
Romigi, A., Izzi, F., Pisani, V., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03352.x · Cited by 83
The impact of alternative splicing in vivo: Mouse models show the way
Möröy, T., & Heyd, F. (2007) · RNA · doi:10.1261/rna.554607 · Cited by 80
Extensive alternative splicing transitions during postnatal skeletal muscle development are required for calcium handling functions
Brinegar, A. E., Xia, Z., Loehr, J. A., Li, W., Rodney, G. G., & Cooper, T. A. (2017) · eLife · doi:10.7554/elife.27192 · Cited by 80
Loss of muscleblind-like 1 results in cardiac pathology and persistence of embryonic splice isoforms
Dixon, D. M., Choi, J., El‐Ghazali, A., Park, S. Y., Roos, K. P., Jordan, M. C., Fishbein, M. C., Comai, L., & Reddy, S. (2015) · Scientific Reports · doi:10.1038/srep09042 · Cited by 82
Mouse model of muscleblind-like 1 overexpression: skeletal muscle effects and therapeutic promise
Chamberlain, C. M., & Ranum, L. P. W. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds306 · Cited by 91
The hallmarks of myotonic dystrophy type 1 muscle dysfunction
Ozimski, L. L., Sabater-Arcis, M., Bargiela, A., & Artero, R. D. (2020) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12674 · Cited by 81
Autoregulated Splicing of muscleblind-like 1 (MBNL1) Pre-mRNA
Gates, D. P., Coonrod, L. A., & Berglund, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.236547 · Cited by 85
Analysis of Exonic Regions Involved in Nuclear Localization, Splicing Activity, and Dimerization of Muscleblind-like-1 Isoforms
Tran, H., Marmier‐Gourrier, N., Lemercier-Neuillet, C., Dhaenens, C., Vautrin, A., Fernández-Gómez, F.-J., Arandel, L., Carpentier, C., Obriot, H., Eddarkaoui, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.194928 · Cited by 82
Muscleblind-Like Proteins
Holt, I., Jacquemin, V., Fardaei, M., Sewry, C. A., Butler-Browne, G. S., Furling, D., Brook, J. D., & Morris, G. E. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080520 · Cited by 80
The hypocretin neurotransmission system in myotonic dystrophy type 1
Ciafaloni, E., Mignot, E. J.-M., Sansone, V., Hilbert, J. E., Lin, L. L., Lin, X., Liu, L. C., Pigeon, W. R., Perlis, M. L., & Thornton, C. A. (2008) · Neurology · doi:10.1212/01.wnl.0000296827.20167.98 · Cited by 79
Self-citation
Expression of RNA CCUG Repeats Dysregulates Translation and Degradation of Proteins in Myotonic Dystrophy 2 Patients
Salisbury, E. A., Schoser, B. G. H., Schneider‐Gold, C., Wang, G.-L., Huichalaf, C. H., Jin, B., Sirito, M., Sarkar, P. S., Krahe, R., Timchenko, N. A., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090047 · Cited by 87
Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1
Lueck, J. D., Lungu, C., Mankodi, A. K., Osborne, R. J., Welle, S. L., Dirksen, R. T., & Thornton, C. A. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00336.2006 · Cited by 81
Self-citation
Nuclear localization of MBNL1: splicing-mediated autoregulation and repression of repeat-derived aberrant proteins
Kino, Y., Washizu, C., Kurosawa, M., Oma, Y., Hattori, N., Ishiura, S., & Nukina, N. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu492 · Cited by 84
m1A in CAG repeat RNA binds to TDP-43 and induces neurodegeneration
Sun, Y., Dai, H., Dai, X., Yin, J., Cui, Y., Liu, X., Gonzalez, G. M., Yuan, J. J., Tang, F., Wang, N., et al. (2023) · Nature · doi:10.1038/s41586-023-06701-5 · Cited by 89
Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs
François, V., Klein, A. F., Beley, C., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1958 · Cited by 79
From dynamic combinatorial ‘hit’ to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy
Ofori, L. O., Hoskins, J. W., Nakamori, M., Thornton, C. A., & Miller, B. L. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks298 · Cited by 77
Self-citation
Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila model
Bargiela, A., Cerro-Herreros, E., Fernández‐Costa, J. M., Vilchez, J. J., Llamusí, B., & Artero, R. D. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.018127 · Cited by 84
Stochastic and reversible aggregation of mRNA with expanded CUG-triplet repeats
Querido, E., Gallardo, F., Beaudoin, M., Ménard, C., & Chartrand, P. (2011) · Journal of Cell Science · doi:10.1242/jcs.073270 · Cited by 79
Mechanistic determinants of MBNL activity
Sznajder, Ł. J., Michalak, M., Taylor, K., Cywoniuk, P., Kabza, M., Wojtkowiak-Szlachcic, A., Matłoka, M., Konieczny, P., & Sobczak, K. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw915 · Cited by 76
Myotonic dystrophy CTG expansion affects synaptic vesicle proteins, neurotransmission and mouse behaviour
Hernández‐Hernández, Ó., Guiraud-Dogan, C., Sicot, G., Huguet-Lachon, A., Luilier, S., Steidl, E., Saenger, S., Marciniak, E., Obriot, H., Chevarin, C., et al. (2013) · Brain · doi:10.1093/brain/aws367 · Cited by 86
Self-citation
High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines
Ketley, A., Chen, C. Z., Li, X., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt542 · Cited by 75
Antisense Oligonucleotide-Based Therapies for Diseases Caused by pre-mRNA Processing Defects
Rigo, F., Seth, P. P., & Bennett, C. F. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1221-6_9 · Cited by 72
Expanded CTG repeats trigger miRNA alterations in Drosophila that are conserved in myotonic dystrophy type 1 patients
Fernández‐Costa, J. M., García-López, A., Zúñiga, S., Fernández‐Pedrosa, V., Felipo-Benavent, A., Mata, M., Jaka, O., Aiastui, A., Hernández‐Torres, F., Aguado, B., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds478 · Cited by 74
Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics
Chau, A. C., & Kalsotra, A. (2014) · Developmental Dynamics · doi:10.1002/dvdy.24240 · Cited by 81
Alternative splicing analysis in human monocytes and macrophages reveals MBNL1 as major regulator
Liu, H., Lorenzini, P. A., Zhang, F., Xu, S., Wong, M. S. M., Zheng, J., & Roca, X. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky401 · Cited by 74
New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats
Laurent, F.-X., Sureau, A., Klein, A. F., Trouslard, F., Gasnier, E., Furling, D., & Marie, J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1228 · Cited by 73
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcriptsPreprint
Fish, L., Pencheva, N., Goodarzi, H., Tran, H., Yoshida, M., & Tavazoie, S. F. (2016) · Genes & Development · doi:10.1101/gad.270645.115 · Cited by 78
Absence of a differentiation defect in muscle satellite cells from DM2 patients
Pelletier, R., Hamel, F., Beaulieu, D., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.009 · Cited by 72
Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2
Vihola, A., Bachinski, L. L., Sirito, M., Olufemi, S.-E., Hajibashi, S., Baggerly, K., Raheem, O., Haapasalo, H. K., Suominen, T., Holmlund-Hampf, J., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0637-6 · Cited by 72
miR-30-5p Regulates Muscle Differentiation and Alternative Splicing of Muscle-Related Genes by Targeting MBNL
Zhang, B., Cai, H., Wei, X., Sun, J., Lan, X., Lei, C., Lin, F., Qi, X., Plath, M. W., & Chen, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020182 · Cited by 71
Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
Meola, G. (2013) · PubMed · Cited by 70
Conserved functional antagonism of CELF and MBNL proteins controls stem cell-specific alternative splicing in planarians
Solana, J., Irimia, M., Ayoub, S., Orejuela, M. R., Zywitza, V., Jens, M., Tapial, J., Ray, D., Morris, Q., Hughes, T. R., et al. (2016) · eLife · doi:10.7554/elife.16797 · Cited by 70
ATXN2‐AS , a gene antisense to ATXN2 , is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis
Li, P. P., Sun, X., Xia, G., Arbez, N., Paul, S., Zhu, S., Peng, H. B., Ross, C. A., Koeppen, A. H., Margolis, R. L., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24761 · Cited by 70
MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia
Itskovich, S. S., Gurunathan, A., Clark, J. P., Burwinkel, M., Wunderlich, M., Berger, M. R., Kulkarni, A., Chetal, K., Venkatasubramanian, M., Salomonis, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15733-8 · Cited by 70
tappAS: a comprehensive computational framework for the analysis of the functional impact of differential splicing
de la Fuente, L., Arzalluz-Luque, Á., Tardáguila, M., del Risco, H., Martí, C., Tarazona, S., Salguero, P., Scott, R., Lerma-Aguilera, A., Alastrue‐Agudo, A., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02028-w · Cited by 66
Splicing alterations in healthy aging and disease
Angarola, B. L., & Anczuków, O. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1643 · Cited by 73
RNA toxicity in human disease and animal models: From the uncovering of a new mechanism to the development of promising therapies
Sicot, G., & Gomes-Pereira, M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.002 · Cited by 78
Prediction of clustered RNA-binding protein motif sites in the mammalian genome
Zhang, C., Lee, K., Swanson, M. S., & Darnell, R. B. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt421 · Cited by 65
Self-citation
Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy
André, L. M., Ausems, C. R. M., Wansink, D. G., & Wieringa, B. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00368 · Cited by 68
Defining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains
Smith, K. P., Byron, M., Johnson, C. V., et al. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200706048 · Cited by 67
Skeletal muscle CaV1.1 channelopathies
Flucher, B. E. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02368-3 · Cited by 73
CUG-BP, Elav-like family (CELF)-mediated alternative splicing regulation in the brain during health and disease
Ladd, A. N. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.12.003 · Cited by 74
Mapping and modeling the genomic basis of differential RNA isoform expression at single-cell resolution with LR-Split-seq
Rebboah, E., Reese, F., Williams, K., Balderrama-Gutierrez, G., McGill, C., Trout, D., Rodriguez, I., Liang, H., Wold, B. J., & Mortazavi, A. (2021) · Genome Biology · doi:10.1186/s13059-021-02505-w · Cited by 58
Alternative Splicing in Disease
Orengo, J. P., & Cooper, T. A. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-77374-2_13 · Cited by 65
High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany
Suominen, T., Schoser, B. G. H., Raheem, O., et al. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0010-z · Cited by 64
Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism
Meola, G., & Cardani, R. (2015) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-150088 · Cited by 64
Rational Design of Bioactive, Modularly Assembled Aminoglycosides Targeting the RNA that Causes Myotonic Dystrophy Type 1
Childs‐Disney, J. L., Parkesh, R., Nakamori, M., et al. (2012) · ACS Chemical Biology · doi:10.1021/cb3001606 · Cited by 63
Self-citation
Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity
Terenzi, F., & Ladd, A. N. (2010) · RNA Biology · doi:10.4161/rna.7.1.10401 · Cited by 63
Muscleblind‐like 2 (Mbnl2) ‐deficient mice as a model for myotonic dystrophy
Hao, M., Akrami, K., Wei, K., Diego, C. D., Che, N., Ku, J.-H., Tidball, J. G., Graves, M. C., Shieh, P. B., & Chen, F. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21428 · Cited by 63
RBFOX1 Cooperates with MBNL1 to Control Splicing in Muscle, Including Events Altered in Myotonic Dystrophy Type 1
Klinck, R., Fourrier, A., Thibault, P., Toutant, J., Durand, M., Lapointe, E., Caillet‐Boudin, M., Sergeant, N., Gourdon, G., Meola, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107324 · Cited by 63
Two high-throughput screening assays for aberrant RNA–protein interactions in myotonic dystrophy type 1
Chen, C. Z., Sobczak, K., Hoskins, J. W., Southall, N. T., Marugán, J., Zheng, W., Thornton, C. A., & Austin, C. P. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5604-0 · Cited by 62
Self-citation
Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects
Hoskins, J. W., Ofori, L. O., Chen, C. Z., Kumar, A., Sobczak, K., Nakamori, M., Southall, N. T., Patnaik, S., Marugán, J., Zheng, W., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku275 · Cited by 62
Self-citation
Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy
Bisset, D., Stępniak-Konieczna, E., Zavaljevski, M., Wei, J., Carter, G. T., Weiss, M. D., & Chamberlain, J. R. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv219 · Cited by 68
Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variables
Cudia, P., Bernasconi, P., Chiodelli, R., Mangiola, F., Bellocci, F., Russo, A. D., Angelini, C. I., Romeo, V., Melacini, P., Politano, L., et al. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.162594 · Cited by 60
Alternative splicing dysregulation secondary to skeletal muscle regeneration
Orengo, J. P., Ward, A. J., & Cooper, T. A. (2010) · Annals of Neurology · doi:10.1002/ana.22278 · Cited by 59
MBNL expression in autoregulatory feedback loops
Konieczny, P., Stępniak-Konieczna, E., & Sobczak, K. (2017) · RNA Biology · doi:10.1080/15476286.2017.1384119 · Cited by 60
Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 Mice
Scrudato, M. L., Poulard, K., Sourd, C., Tomé, S., Klein, A. F., Corre, G., Huguet-Lachon, A., Furling, D., Gourdon, G., & Buj‐Bello, A. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.05.021 · Cited by 67
RNA-Binding Proteins in the Post-transcriptional Control of Skeletal Muscle Development, Regeneration and Disease
Shi, D., & Grifone, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.738978 · Cited by 58
Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: Two individual consequences of CUG trinucleotide repeats
Dhaenens, C., Schraen‐Maschke, S., Tran, H., Vingtdeux, V., Ghanem, D., Leroy, O., Delplanque, J., Vanbrussel, E., Delacourte, A., Vermersch, P., et al. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.020 · Cited by 59
RNA dysregulation in neurodegenerative diseases
Li, Y., & Sun, S. (2025) · The EMBO Journal · doi:10.1038/s44318-024-00352-6 · Cited by 65
Systemic Delivery of a Peptide-Linked Morpholino Oligonucleotide Neutralizes Mutant RNA Toxicity in a Mouse Model of Myotonic Dystrophy
Leger, A. J., Mosquea, L. M., Clayton, N. P., et al. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0404 · Cited by 58
Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1
Wheeler, T. M., Krym, M., & Thornton, C. A. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2006.12.015 · Cited by 58
Self-citation
Decoding muscle alternative splicing
Llorian, M., & Smith, C. W. J. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.03.006 · Cited by 59
Dmpkgene deletion or antisense knockdown does not compromise cardiac or skeletal muscle function in mice
Carrell, S., Carrell, E. M., Auerbach, D. S., Pandey, S., Bennett, C. F., Dirksen, R. T., & Thornton, C. A. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw266 · Cited by 57
Self-citation
Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophies
Antoury, L., Hu, N., Balaj, L., Das, S., Georghiou, S., Darras, B. T., Clark, T., Breakefield, X. O., & Wheeler, T. M. (2018) · Nature Communications · doi:10.1038/s41467-018-06206-0 · Cited by 57
The sustained expression of Cas9 targeting toxic RNAs reverses disease phenotypes in mouse models of myotonic dystrophy type 1
Batra, R., Nelles, D. A., Roth, D., Krach, F., Nutter, C. A., Tadokoro, T., Thomas, J. D., Sznajder, Ł. J., Blue, S. M., Gutierrez, H. L., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00607-7 · Cited by 57
Self-citation
The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients
Botta, A., Rinaldi, F., Catalli, C., Vergani, L., Bonifazi, E., Romeo, V., Loro, E., Viola, A., Angelini, C. I., & Novelli, G. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.058909 · Cited by 56
Generation of Neural Cells from DM1 Induced Pluripotent Stem Cells As Cellular Model for the Study of Central Nervous System Neuropathogenesis
Xia, G., Santostefano, K. E., Goodwin, M., Liu, J., Subramony, S. H., Swanson, M. S., Terada, N., & Ashizawa, T. (2013) · Cellular Reprogramming · doi:10.1089/cell.2012.0086 · Cited by 56
Self-citation
Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders
Bachinski, L. L., Sirito, M., Böhme, M., Baggerly, K., Udd, B., & Krahe, R. (2010) · Muscle & Nerve · doi:10.1002/mus.21789 · Cited by 54
Molecular mechanisms of muscle atrophy in myotonic dystrophies
Timchenko, L. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.06.010 · Cited by 53
Muscleblind-like 1 (Mbnl1) regulates pre-mRNA alternative splicing during terminal erythropoiesis
Cheng, A. W., Shi, J., Wong, P., Luo, K. L., Trepman, P. C., Wang, E. T., Choi, H., Burge, C. B., & Lodish, H. F. (2014) · Blood · doi:10.1182/blood-2013-12-542209 · Cited by 51
Antisense Oligonucleotides: Rising Stars in Eliminating RNA Toxicity in Myotonic Dystrophy
Gao, Z., & Cooper, T. A. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.212 · Cited by 51
Alternative splicing regulation by Muscleblind proteins: from development to disease
Fernández‐Costa, J. M., Llamusí, B., García-López, A., & Artero, R. D. (2011) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2011.00180.x · Cited by 54
Ubiquitination of MBNL1 Is Required for Its Cytoplasmic Localization and Function in Promoting Neurite Outgrowth
Wang, P.-Y., Chang, K., Lin, Y.-M., Kuo, T., & Wang, G. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.025 · Cited by 51
HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy
Li, M., Zhuang, Y., Batra, R., Thomas, J. D., Mao, L., Nutter, C. A., Scotti, M. M., Carter, H. A., Wang, Z. J., Huang, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907297117 · Cited by 51
Self-citation
Myotonic Dystrophy: Therapeutic Strategies for the Future
Wheeler, T. M. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.08.001 · Cited by 53
Nuclear retention of full-length HTT RNA is mediated by splicing factors MBNL1 and U2AF65
Sun, X., Li, P. P., Zhu, S., Cohen, R. L., Marque, L. O., Ross, C. A., Pulst, S. M., Chan, H. Y. E., Margolis, R. L., & Rudnicki, D. D. (2015) · Scientific Reports · doi:10.1038/srep12521 · Cited by 50
DDX6 regulates sequestered nuclear CUG-expanded DMPK-mRNA in dystrophia myotonica type 1
Pettersson, O. J., Aagaard, L., Andrējeva, D., Thomsen, R., Jensen, T. G., & Damgaard, C. K. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku352 · Cited by 49
Altered mRNA splicing of dystrophin in type 1 myotonic dystrophy
Nakamori, M., Kimura, T., Fujimura, H., et al. (2007) · Muscle & Nerve · doi:10.1002/mus.20809 · Cited by 49
Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models
Bargiela, A., Sabater-Arcis, M., Espinosa-Espinosa, J., Zulaica, M., de Munaín, A. L., & Artero, R. D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820297116 · Cited by 56
Cytoplasmic CUG RNA Foci Are Insufficient to Elicit Key DM1 Features
Dansithong, W., Wolf, C. M., Sarkar, P. S., Paul, S., Chiang, A., Holt, I., Morris, G. E., Branco, D. M., Sherwood, M. C., Comai, L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003968 · Cited by 49
Muscleblind-like 1 activates insulin receptor exon 11 inclusion by enhancing U2AF65 binding and splicing of the upstream intron
Echeverria, G. V., & Cooper, T. A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1020 · Cited by 50
Perturbation of U2AF65/NXF1-mediated RNA nuclear export enhances RNA toxicity in polyQ diseases
Tsoi, H., Lau, T. C., Lau, K., & Chan, H. Y. E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr297 · Cited by 48
Cardiovascular manifestations of myotonic dystrophy
Wahbi, K., & Furling, D. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.06.001 · Cited by 48
A Small Molecule that Binds an RNA Repeat Expansion Stimulates Its Decay via the Exosome Complex
Angelbello, A. J., Benhamou, R. I., Rzuczek, S. G., Choudhary, S., Tang, Z., Chen, J. L., Roy, M., Wang, K. W., Yildirim, I., Jun, A. S., et al. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.10.007 · Cited by 49
Self-citation
Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1
Benichou, S. A., Jauvin, D., Serres‐Bérard, T. D., Pierre, M., Ling, K., Bennett, C. F., Rigo, F., Gourdon, G., Chahine, M., & Puymirat, J. (2022) · Gene Therapy · doi:10.1038/s41434-022-00316-7 · Cited by 48
Myotonic Dystrophies: A Genetic Overview
Soltanzadeh, P. (2022) · Genes · doi:10.3390/genes13020367 · Cited by 58
Gain of RNA function in pathological cases: Focus on myotonic dystrophy
Klein, A. F., Gasnier, E., & Furling, D. (2011) · Biochimie · doi:10.1016/j.biochi.2011.06.028 · Cited by 50
Autoregulation of MBNL1 function by exon 1 exclusion from MBNL1 transcript
Konieczny, P., Stępniak-Konieczna, E., Taylor, K., Sznajder, Ł. J., & Sobczak, K. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1158 · Cited by 48
Common variants near MBNL1 and NKX2-5 are associated with infantile hypertrophic pyloric stenosis
Feenstra, B., Geller, F., Krogh, C., Hollegaard, M. V., Gørtz, S., Boyd, H. A., Murray, J. C., HOUGAARD, D. M., & Melbye, M. (2012) · Nature Genetics · doi:10.1038/ng.1067 · Cited by 43
Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1
Morriss, G. R., Rajapakshe, K., Huang, S., Coarfa, C., & Cooper, T. A. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy192 · Cited by 44
RNA-Binding Protein Rbm24 as a Multifaceted Post-Transcriptional Regulator of Embryonic Lineage Differentiation and Cellular Homeostasis
Grifone, R., Shao, M., Saquet, A., & Shi, D. (2020) · Cells · doi:10.3390/cells9081891 · Cited by 46
Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy
Tanner, M. K., Tang, Z., & Thornton, C. A. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab022 · Cited by 46
Self-citation
Derepressing muscleblind expression by miRNA sponges ameliorates myotonic dystrophy-like phenotypes in Drosophila
Cerro-Herreros, E., Fernández‐Costa, J. M., Sabater-Arcis, M., Llamusí, B., & Artero, R. D. (2016) · Scientific Reports · doi:10.1038/srep36230 · Cited by 45
Of Mice and Men: Advances in the Understanding of Neuromuscular Aspects of Myotonic Dystrophy
Bráz, S., Acquaire, J., Gourdon, G., & Gomes-Pereira, M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00519 · Cited by 45
Aberrant Expression of a Non-muscle RBFOX2 Isoform Triggers Cardiac Conduction Defects in Myotonic Dystrophy
Misra, C., Bangru, S., Lin, F., Lam, K. L. H., Koenig, S. N., Lubbers, E. R., Hedhli, J., Murphy, N. P., Parker, D. J., Dobrucki, L. W., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.01.037 · Cited by 54
Aberrantly spliced α-dystrobrevin alters α-syntrophin binding in myotonic dystrophy type 1
Nakamori, M., Kimura, T., Kubota, T., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000302174.08951.cf · Cited by 45

Authors: Lin, X., Miller, J. W., Mankodi, A., Kanadia, R. N., Yuan, Y., Moxley, R. T., Swanson, M. S., & Thornton, C. A.
Affiliations: University of Rochester Medicine (US)
University of Florida (US)
Corresponding author: Thornton, Charles A.
ORCID: Mankodi, Ami
Kanadia, Rahul N.
Yuan, Yuan
Swanson, Maurice S.
Thornton, Charles A.
Venue: Human Molecular Genetics
Publisher: Oxford University Press (OUP)
Published: 2006-05-22
Volume: 15
Issue: 13
Pages: 2087-2097
ISSN: 0964-6906 (ISSN-L)
1460-2083
DOI: 10.1093/hmg/ddl132
OpenAlex: W2140074138
Semantic Scholar: 1b600bfc756195b662624998312e8d206442a550
Cited by: 510
References: 35
Citations by year: 2026: 19 · 2025: 19 · 2024: 20 · 2023: 19 · 2022: 17 · 2021: 27 · 2020: 29 · 2019: 24 · 2018: 27 · 2017: 19 · 2016: 26 · 2015: 27 · 2014: 37 · 2013: 34 · 2012: 36
FWCI: 9.66
Type: journal article
Language: en
Open access: closed
Locations: Human Molecular Genetics (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01ar002250-007)
National Institute of Neurological Disorders and Stroke (NS-48843)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR-48143, R01AR049077, K24AR048143, R01AR046799, AR02250, R01AR046806, AR46806)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords: myotonic dystrophy, MBNL1, MBNL2, CUG repeat expansion, alternative splicing, nuclear foci, skeletal muscle development, myotonic dystrophy type 1, myotonic dystrophy type 2
MeSH terms: Animals, Cell Nucleus, Humans, Mice, Transgenic, Molecular Sequence Data, Myotonic Dystrophy, Time Factors, Immunoblotting, RNA-Binding Proteins, Alternative Splicing, Mice, Knockout, Muscle, Skeletal, Gene Expression Regulation, Developmental, Trinucleotide Repeat Expansion, Reverse Transcriptase Polymerase Chain Reaction, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks